SlideShare una empresa de Scribd logo
1 de 21
“ FAST, LOW-COST DEVICE
USES THE CLOUD TO SPEED
 UP DIAGNOSTIC TESTING
 FOR HIV AND MORE” AND
“NOVEL TEST STREAMLINES
TESTING FOR HUNTINGTON
          DISEASE”

        MANUELA JIMÉNEZ
           OBANDO
      MEDICINE STUDENT UPB 2013
There are many
techniques that are used
 in molecular biology, for
      example, PCR
    (polymerase chain
    reaction) or ELISA.




 PCR pretends to amplify
   DNA o RNA, using
 enzymes in vitro, and is
 useful in the detection of
  genetical disease like
        Huntington.
ELISA is a low-cost immunoassay
 technique that finding antibodies
or antigens, is really useful in the
  detection of different diseases.
“FAST LOW-COST DEVICE
USES THE CLOUD TO SPPED
 UP DIAGNOSTIC TESTING
   FOR HIV AND MORE”
Clinical Chemistry, January
          18,2013
“FAST LOW-COST DEVICE USES THE CLOUD TO
SPPED UP DIAGNOSTIC TESTING FOR HIV AND
                 MORE”

  Samuel K. Sia developed
 an advanced technique that
  he proposed to provide a         It consists of a handheld
                                  mobile device that only by
  disgnostic service with a
                                 picking a finger and getting a
   lab-quality, to people in     sample, can give the results
 remote areas of the world ,       in just 15 minutes (faster
  who can´t go to a hospital              than ELISA).
           facility.

                                This test allows a
                                     real-time
                               synchronization of
                                diagnostic results
                               with patient records
                                   in the cloud.
“FAST LOW-COST DEVICE USES THE CLOUD TO
SPPED UP DIAGNOSTIC TESTING FOR HIV AND
                 MORE”

                          The possibility to give
                           quick results allows
                          real-time data upload,
                            resulting in easier
                             epidemiological
                          analysis; this is one of
                         the contributions to the
                            medical world: the
                           prevention of some
                            diseases (HIV for
                                 example).
“FAST LOW-COST DEVICE USES THE CLOUD TO
SPPED UP DIAGNOSTIC TESTING FOR HIV AND
                 MORE”


       Sia has now other bigger
      objetives with his “lab on a    “To implement an
                 chip”:                 antenatal care
                                           panel for
                                     diagnosing HIV and
                                     sexually transmitted
                                         diseases for
                                     pregnant women in
                                           Rwanda”
“FAST LOW-COST DEVICE USES THE CLOUD TO
SPPED UP DIAGNOSTIC TESTING FOR HIV AND
                 MORE”

                             I think what Sia is doing is a great
                             contribution to the development of
                           medical technologies, because it brings
                           the possibility of getting a diagnosis to

     OBSERVATION:
     OBSERVATION:      people who can´t go to a health facility or
                           who live in undeveloped countries. On
                       the other side, this technology facilitates
                             the information to epidemiological
                                           studies.
                        
“NOVEL TEST
STREAMLINES TESTING
   FOR HUNTINGTON
        DISEASE”
 The Journal of Molecular
 Diagnostics, Volume 15,
  Issue 2 (March 2013)
  published by Elsevier.
“NOVEL TEST STREAMLINES TESTING
        FOR HUNTINGTON DISEASE”
                                   This disease is a neurodegenerative
                                       disorder (oringinated by the
   HUNTINGTON                       Huntingtina, a protein encoded by
                                      repeted sequences of “CAG”)
     DISEASE
                                     This protein accumulation affects
                                  specially the brain and the expression of
                                    symptoms is directly related with the
                                            number of repetitions.


                                  Symptoms are often related with problems in
                                       mood or cognition, diminished muscle
                                     coordination, with consequences which are
                                   evident on walking, speaking and other daily
                                  life activities. This people also has changes in
                                            personality and thinking skills.
Neurons with Nuclear inclusions
“NOVEL TEST STREAMLINES TESTING
    FOR HUNTINGTON DISEASE”


                       A new test :: TP PCR
                          A new test TP PCR




     Generates
 accurate results by            The study used 246 samples that were
    counting the                previously analyzed with other methods
  repetitions of the             (with possitive and negative results for
   sequence and                 HD), and the samples results coincided.
    doesn´t need
   additional tests
“NOVEL TEST STREAMLINES TESTING
    FOR HUNTINGTON DISEASE”


    The TP PCR based its
                                    Even 101 repetitions could
  analysis in the fact than 39
                                    be accurately sized with TP
 or more repetitions of “CAG”
                                                PCR.
    determinates the risk of
                                      Also samples that were
       developing HD.
                                     really difficult to analyze
                                     with other methods, and
                                        were considered a
                                    challenging, had easy and
 Another advantage of TP PCR         accurate results with this
   is the ability to identify the            new test.
 homozygous normal samples
     and avoid further tests.
  However, in children further
     tests are recomended.
“NOVEL TEST STREAMLINES TESTING
    FOR HUNTINGTON DISEASE”

                      I think that using TP PCR it is
                    possible to reduce the number of

  OBSERVATION:      false negative, that would be really
                      useful for people who has HD,
                    because it is a grave disease that
                       affect in a big way the life of
                     patients who suffer from it; they
                     can develop diminished muscle
                      coordination that is evident on
                     walking and speaking during the
                     daily life. This people also have
                       changes in personality and
                              thinking skills.
MEDICAL UTILITY


  The easier, and more
  effective diagnosis of a
     lot of diseases like
         Huntington.
MEDICAL UTILITY


Reduce the number of false
negatives in some diseases.
MEDICAL UTILITY

     …And gives a faster way to
         prevent and start
      a treatment in positive
              cases.
MEDICAL UTILITY

      Gives the possibility of a
   diagnosis and control tests to
places in the world without access
 to specialized laboratories. And
do it with a low-cost and fast way.
BIBLIOGRAFÍA
   Martínez,Lina;        Vargas,Natalia;        Toro,Eduardo;
    Pamplona,Ana; Quevedo,Esteban.“Biología molecular”.Ed7.
    2012. Pp.121-127
   Mohamed Jama, Alison Millson, Christine E. Miller, Elaine
    Lyon. Triplet Repeat Primed PCR Simplifies Testing for
    Huntington Disease. The Journal of Molecular Diagnostics,
    2013; DOI: 10.1016/j.jmoldx.2012.09.005
    C. D. Chin, Y. K. Cheung, T. Laksanasopin, M. M. Modena,
    S. Y. Chin, A. A. Sridhara, D. Steinmiller, V. Linder, J.
    Mushingantahe, G. Umviligihozo, W. El-Sadr, S. K.
    Sia. Mobile Device for Disease Diagnosis and Data
    Tracking      in    Resource-Limited     Settings. Clinical
    Chemistry, 2013; DOI: 10.1373/clinchem.2012.199596
 
Presentación plegable biomol manuela j

Más contenido relacionado

Similar a Presentación plegable biomol manuela j

Plegable molecular
Plegable molecularPlegable molecular
Plegable molecular
VaLe Ortega
 
Plegable molecular
Plegable molecularPlegable molecular
Plegable molecular
VaLe Ortega
 
n engl j med 368;24 nejm.org june 13, 2013 2319s o u n d i.docx
n engl j med 368;24 nejm.org june 13, 2013 2319s o u n d i.docxn engl j med 368;24 nejm.org june 13, 2013 2319s o u n d i.docx
n engl j med 368;24 nejm.org june 13, 2013 2319s o u n d i.docx
rosemarybdodson23141
 
Trabajo biomol 2
Trabajo biomol 2Trabajo biomol 2
Trabajo biomol 2
therong
 

Similar a Presentación plegable biomol manuela j (20)

Plegable molecular
Plegable molecularPlegable molecular
Plegable molecular
 
Plegable molecular
Plegable molecularPlegable molecular
Plegable molecular
 
Ppt plegable 97
Ppt plegable 97Ppt plegable 97
Ppt plegable 97
 
Walker_JPF00867_Research
Walker_JPF00867_ResearchWalker_JPF00867_Research
Walker_JPF00867_Research
 
PCR News
PCR NewsPCR News
PCR News
 
Ppt plegable
Ppt plegablePpt plegable
Ppt plegable
 
Ppt plegable
Ppt plegablePpt plegable
Ppt plegable
 
Medical genetics
Medical geneticsMedical genetics
Medical genetics
 
NGS for Infectious Disease Diagnostics: An Opportunity for Growth
NGS for Infectious Disease Diagnostics: An Opportunity for Growth NGS for Infectious Disease Diagnostics: An Opportunity for Growth
NGS for Infectious Disease Diagnostics: An Opportunity for Growth
 
Molecular screening assay must have sample adequacy control
Molecular screening assay must have sample adequacy controlMolecular screening assay must have sample adequacy control
Molecular screening assay must have sample adequacy control
 
Antibiotic-pathogen-biomarker screening by PCR must have SAC
Antibiotic-pathogen-biomarker screening by PCR must have SACAntibiotic-pathogen-biomarker screening by PCR must have SAC
Antibiotic-pathogen-biomarker screening by PCR must have SAC
 
Neuro-Fuzzy Approach for Diagnosing and Control of Tuberculosi
Neuro-Fuzzy Approach for Diagnosing and Control of TuberculosiNeuro-Fuzzy Approach for Diagnosing and Control of Tuberculosi
Neuro-Fuzzy Approach for Diagnosing and Control of Tuberculosi
 
NEURO-FUZZY APPROACH FOR DIAGNOSING AND CONTROL OF TUBERCULOSIS
NEURO-FUZZY APPROACH FOR DIAGNOSING AND CONTROL OF TUBERCULOSISNEURO-FUZZY APPROACH FOR DIAGNOSING AND CONTROL OF TUBERCULOSIS
NEURO-FUZZY APPROACH FOR DIAGNOSING AND CONTROL OF TUBERCULOSIS
 
Genomics in Public Health
Genomics in Public HealthGenomics in Public Health
Genomics in Public Health
 
chapter2-191105204556.pdf
chapter2-191105204556.pdfchapter2-191105204556.pdf
chapter2-191105204556.pdf
 
n engl j med 368;24 nejm.org june 13, 2013 2319s o u n d i.docx
n engl j med 368;24 nejm.org june 13, 2013 2319s o u n d i.docxn engl j med 368;24 nejm.org june 13, 2013 2319s o u n d i.docx
n engl j med 368;24 nejm.org june 13, 2013 2319s o u n d i.docx
 
Trabajo biomol 2
Trabajo biomol 2Trabajo biomol 2
Trabajo biomol 2
 
TB Diagnosis (Latent and Active).
TB Diagnosis (Latent and Active).TB Diagnosis (Latent and Active).
TB Diagnosis (Latent and Active).
 
Chapter 2.2 screening test
Chapter 2.2 screening testChapter 2.2 screening test
Chapter 2.2 screening test
 
Novel approach to diagnosis of mycobacterial and bacterial
Novel approach to diagnosis of mycobacterial and bacterialNovel approach to diagnosis of mycobacterial and bacterial
Novel approach to diagnosis of mycobacterial and bacterial
 

Presentación plegable biomol manuela j

  • 1. “ FAST, LOW-COST DEVICE USES THE CLOUD TO SPEED UP DIAGNOSTIC TESTING FOR HIV AND MORE” AND “NOVEL TEST STREAMLINES TESTING FOR HUNTINGTON DISEASE” MANUELA JIMÉNEZ OBANDO MEDICINE STUDENT UPB 2013
  • 2.
  • 3.
  • 4. There are many techniques that are used in molecular biology, for example, PCR (polymerase chain reaction) or ELISA. PCR pretends to amplify DNA o RNA, using enzymes in vitro, and is useful in the detection of genetical disease like Huntington.
  • 5. ELISA is a low-cost immunoassay technique that finding antibodies or antigens, is really useful in the detection of different diseases.
  • 6. “FAST LOW-COST DEVICE USES THE CLOUD TO SPPED UP DIAGNOSTIC TESTING FOR HIV AND MORE” Clinical Chemistry, January 18,2013
  • 7. “FAST LOW-COST DEVICE USES THE CLOUD TO SPPED UP DIAGNOSTIC TESTING FOR HIV AND MORE” Samuel K. Sia developed an advanced technique that he proposed to provide a It consists of a handheld mobile device that only by disgnostic service with a picking a finger and getting a lab-quality, to people in sample, can give the results remote areas of the world , in just 15 minutes (faster who can´t go to a hospital than ELISA). facility. This test allows a real-time synchronization of diagnostic results with patient records in the cloud.
  • 8. “FAST LOW-COST DEVICE USES THE CLOUD TO SPPED UP DIAGNOSTIC TESTING FOR HIV AND MORE” The possibility to give quick results allows real-time data upload, resulting in easier epidemiological analysis; this is one of the contributions to the medical world: the prevention of some diseases (HIV for example).
  • 9. “FAST LOW-COST DEVICE USES THE CLOUD TO SPPED UP DIAGNOSTIC TESTING FOR HIV AND MORE” Sia has now other bigger objetives with his “lab on a “To implement an chip”: antenatal care panel for diagnosing HIV and sexually transmitted diseases for pregnant women in Rwanda”
  • 10. “FAST LOW-COST DEVICE USES THE CLOUD TO SPPED UP DIAGNOSTIC TESTING FOR HIV AND MORE” I think what Sia is doing is a great contribution to the development of medical technologies, because it brings the possibility of getting a diagnosis to OBSERVATION: OBSERVATION: people who can´t go to a health facility or who live in undeveloped countries. On the other side, this technology facilitates the information to epidemiological studies.  
  • 11. “NOVEL TEST STREAMLINES TESTING FOR HUNTINGTON DISEASE” The Journal of Molecular Diagnostics, Volume 15, Issue 2 (March 2013) published by Elsevier.
  • 12. “NOVEL TEST STREAMLINES TESTING FOR HUNTINGTON DISEASE” This disease is a neurodegenerative disorder (oringinated by the HUNTINGTON Huntingtina, a protein encoded by repeted sequences of “CAG”) DISEASE This protein accumulation affects specially the brain and the expression of symptoms is directly related with the number of repetitions. Symptoms are often related with problems in mood or cognition, diminished muscle coordination, with consequences which are evident on walking, speaking and other daily life activities. This people also has changes in personality and thinking skills. Neurons with Nuclear inclusions
  • 13. “NOVEL TEST STREAMLINES TESTING FOR HUNTINGTON DISEASE” A new test :: TP PCR A new test TP PCR Generates accurate results by The study used 246 samples that were counting the previously analyzed with other methods repetitions of the (with possitive and negative results for sequence and HD), and the samples results coincided. doesn´t need additional tests
  • 14. “NOVEL TEST STREAMLINES TESTING FOR HUNTINGTON DISEASE” The TP PCR based its Even 101 repetitions could analysis in the fact than 39 be accurately sized with TP or more repetitions of “CAG” PCR. determinates the risk of Also samples that were developing HD. really difficult to analyze with other methods, and were considered a challenging, had easy and Another advantage of TP PCR accurate results with this is the ability to identify the new test. homozygous normal samples and avoid further tests. However, in children further tests are recomended.
  • 15. “NOVEL TEST STREAMLINES TESTING FOR HUNTINGTON DISEASE” I think that using TP PCR it is possible to reduce the number of OBSERVATION: false negative, that would be really useful for people who has HD, because it is a grave disease that affect in a big way the life of patients who suffer from it; they can develop diminished muscle coordination that is evident on walking and speaking during the daily life. This people also have changes in personality and thinking skills.
  • 16. MEDICAL UTILITY The easier, and more effective diagnosis of a lot of diseases like Huntington.
  • 17. MEDICAL UTILITY Reduce the number of false negatives in some diseases.
  • 18. MEDICAL UTILITY …And gives a faster way to prevent and start a treatment in positive cases.
  • 19. MEDICAL UTILITY Gives the possibility of a diagnosis and control tests to places in the world without access to specialized laboratories. And do it with a low-cost and fast way.
  • 20. BIBLIOGRAFÍA  Martínez,Lina; Vargas,Natalia; Toro,Eduardo; Pamplona,Ana; Quevedo,Esteban.“Biología molecular”.Ed7. 2012. Pp.121-127  Mohamed Jama, Alison Millson, Christine E. Miller, Elaine Lyon. Triplet Repeat Primed PCR Simplifies Testing for Huntington Disease. The Journal of Molecular Diagnostics, 2013; DOI: 10.1016/j.jmoldx.2012.09.005  C. D. Chin, Y. K. Cheung, T. Laksanasopin, M. M. Modena, S. Y. Chin, A. A. Sridhara, D. Steinmiller, V. Linder, J. Mushingantahe, G. Umviligihozo, W. El-Sadr, S. K. Sia. Mobile Device for Disease Diagnosis and Data Tracking in Resource-Limited Settings. Clinical Chemistry, 2013; DOI: 10.1373/clinchem.2012.199596